The trade threats could reduce exports to the United States and dampen investment in Europe, dealing a blow to growth at a ...

Repatha: the frontline of US price battles Amgen's Repatha became the first in the new class of cholesterol-lowering PCSK9 inhibitor drugs to gain approval this year, getting the nod in Europe in ...

The start of Donald Trump’s second presidency and Republican control in the 119th Congress raises questions about the future ...

Hospitals and generic drugmakers have join big pharma lobbyists who have said such trade barriers will cause shortages of ...

“A 25% tariff on Canada and Mexico threatens to upend the very supply chains that have made U.S. manufacturing more ...

The US plans to slash the price it pays for the Novo Nordisk A ... of a higher dose of Wegovy disappointed investors and European drug regulators said they were investigating cases of a rare ...

Your guide to what the 2024 US election means for Washington and the world Prices ... in Europe by market capitalisation. Its shares dropped 4.3 per cent to DKr575.6 ($79.33). The group of drugs ...

Novo Nordisk's CEO is not worried about blockbuster semaglutide drugs being added to Medicare drug pricing negotiations this ...